OncoZenge

Sweden
Bromma, Sodermanlands Lan, Sweden, 167 51

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
3
Total equity funding
$3.9M
Last funding
Post IPO Debt / $789,586 / 2025-07-09
Last equity funding
Post IPO Equity / $2.7M
Investors
3
Lead investors
2
Articles
77
Exited on
2021-02-01

Founders and investors

Lead investors

LincSichuan Yangtian Bio-Pharmaceutical

Investors

LincOstersjöstiftelsenSichuan Yangtian Bio-Pharmaceutical